Canagliflozin

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2301 publications

A Microsimulation Model for Chronic Kidney Disease Progression in Type 2 Diabetes Patients in the United States: Michigan Model for Diabetes-Chronic Kidney Disease Model.

A Microsimulation Model for Chronic Kidney Disease Progression in Type 2 Diabetes Patients in the United States: Michigan Model for Diabetes-Chronic Kidney Disease Model.

Journal: Medical decision making : an international journal of the Society for Medical Decision Making

Published: June 19, 2026

Short-term comparative effects of semaglutide, either alone or in conjunction with canagliflozin, on early diabetic kidney disease.

Short-term comparative effects of semaglutide, either alone or in conjunction with canagliflozin, on early diabetic kidney disease.

Journal: Pakistan journal of pharmaceutical sciences

Published: May 22, 2026

Comparative Effectiveness of Individual Sodium Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: Emulation of a Target Trial.

Comparative Effectiveness of Individual Sodium Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: Emulation of a Target Trial.

Journal: Journal of the American Heart Association

Published: May 14, 2026

Endocrinology: What You May Have Missed in 2025.

Endocrinology: What You May Have Missed in 2025.

Journal: Annals of internal medicine

Published: April 13, 2026

Alcoholic Ketoacidosis Accompanied by Acute Gastric Dilation in a Patient with type 2 Diabetes on an SGLT2 Inhibitor and Chronic Alcoholic Abuse.

Alcoholic Ketoacidosis Accompanied by Acute Gastric Dilation in a Patient with type 2 Diabetes on an SGLT2 Inhibitor and Chronic Alcoholic Abuse.

Journal: Internal medicine (Tokyo, Japan)

Published: April 08, 2026

Comparison of effectiveness and safety of bexagliflozin and other sodium-glucose cotransporter 2 inhibitors for type 2 diabetes mellitus in adults: systematic review and network meta-analysis of randomized controlled trials.

Comparison of effectiveness and safety of bexagliflozin and other sodium-glucose cotransporter 2 inhibitors for type 2 diabetes mellitus in adults: systematic review and network meta-analysis of randomized controlled trials.

Journal: Frontiers in endocrinology

Published: March 31, 2026

Gastroprotective potential of canagliflozin in indomethacin-induced peptic ulcer: impact on inflammation, pyroptosis, autophagy, and gut integrity.

Gastroprotective potential of canagliflozin in indomethacin-induced peptic ulcer: impact on inflammation, pyroptosis, autophagy, and gut integrity.

Journal: Biochemical pharmacology

Published: March 30, 2026

Canagliflozin attenuates Parkinson's disease and is associated with modulation of gut-inflammasome-brain axis in rats.

Canagliflozin attenuates Parkinson's disease and is associated with modulation of gut-inflammasome-brain axis in rats.

Journal: Inflammopharmacology

Published: March 22, 2026

Factors That Influence Blood Pressure Changes With the Use of Sodium-Glucose Cotransporter 2 Inhibitors in People With Type 2 Diabetes.

Factors That Influence Blood Pressure Changes With the Use of Sodium-Glucose Cotransporter 2 Inhibitors in People With Type 2 Diabetes.

Journal: Pharmacotherapy

Published: March 20, 2026

Weight loss by sodium-glucose co-transporter 2 inhibitor canagliflozin is followed by rebound in db/db mice but maintained in fat-fed mice via circadian rises in body temperature and locomotor activity.

Weight loss by sodium-glucose co-transporter 2 inhibitor canagliflozin is followed by rebound in db/db mice but maintained in fat-fed mice via circadian rises in body temperature and locomotor activity.

Journal: The journal of physiological sciences : JPS

Published: March 19, 2026

Understanding the Antihyperglycemic Activity of Annona cherimola Leaves. An Edible and Medicinal Plant in Mexico: In Vivo and Ex-Vivo Studies.

Understanding the Antihyperglycemic Activity of Annona cherimola Leaves. An Edible and Medicinal Plant in Mexico: In Vivo and Ex-Vivo Studies.

Journal: Molecules (Basel, Switzerland)

Published: March 19, 2026

C-glycoside synthesis via radical cross-coupling of glycohydrazides.

C-glycoside synthesis via radical cross-coupling of glycohydrazides.

Journal: Nature

Published: March 18, 2026

Showing 1-12 of 2,301

Last Updated: 06/30/2026